Stocklytics Platform
Asset logo for symbol BSX
Boston Scientific
BSX78
$88.25arrow_drop_up1.59%$1.39
High Quality
S&P500
Asset logo for symbol BSX
BSX78

$88.25

arrow_drop_up1.59%
no data available for key stats

There's no data available for key stats

no data available for ratios/profitability stats

There's no data available for ratios/profitability stats

Fundamentals
RPS-
Gross Profit-
EBITDA-
Total Debt-
P/S Ratio-
Enterprise to EBITDA-
Profit Margin-
ROA-
Debt/Equity Ratio-
Payout Ratio-
Industry average yield-
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Stock Performance

BSX-
US Tech-
US Market-

Boston Scientific (BSX) Statistics

Boston Scientific Corp (BSX) is a company engaged in the development, manufacture, and marketing of medical devices. As of the latest statistics, the stock of Boston Scientific Corp is traded on the stock exchange under the ticker symbol BSX. Investors and analysts often evaluate the valuation metrics of the company to determine its fair value. These metrics provide insights into the relative value of the stock compared to its peers and the overall market. Some of the commonly analyzed valuation metrics include price to earnings ratio, price to sales ratio, and price to book ratio.
In terms of fundamentals, Boston Scientific Corp has a strong financial position. The company consistently generates revenue and has a positive profit margin. The stock performance of Boston Scientific Corp is also compared with its sector to assess its relative performance. This comparison helps investors understand whether the stock is outperforming or lagging behind its industry peers. Additionally, Boston Scientific Corp's stock revenue per share indicates the portion of revenue allocated to each outstanding share. This metric provides insights into the revenue generation efficiency of the company.
add Boston Scientific to watchlist

Keep an eye on Boston Scientific

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has Boston Scientific (BSX) stock's performance compared to its sector and the market over the past year?

Over the past year, Boston Scientific (BSX) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 35.38%, Boston Scientific has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 80.81%, it has fallen short of the market average. This comparison highlights Boston Scientific's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of Boston Scientific (BSX) stock?

The PE (Price to Earnings) ratio of Boston Scientific (BSX) is currently 71.75. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.
help

What is the EPS of Boston Scientific (BSX) stock?

The Earnings Per Share (EPS) for Boston Scientific (BSX), calculated on a diluted basis, is $1.23. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of Boston Scientific (BSX) stock?

The operating margin for Boston Scientific (BSX) is 17.06%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of Boston Scientific (BSX) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Boston Scientific (BSX) is $4.14B. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does Boston Scientific (BSX) have?

Boston Scientific (BSX) has a total debt of $11.26B. The net debt, which accounts for cash and cash equivalents against the total debt, is $8.38B.

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level